Search

everythinglearnresearchcommunity

for

Search:↓

Facial feminization surgery helps make facial features more feminine, improving patient satisfaction and safety.

Masculinizing hormone therapy increases the risk of hair loss in transgender and gender-diverse patients.

Transgender and gender-diverse adults on hormone therapy often face drug-hormone interactions, especially with multiple psychotropic medications.

Transgender and gender diverse youth often have skin issues like acne and scarring, but few get referred to dermatologists.

Adults with gender dysphoria on hormone treatment often have skin problems like acne, which are common but not always recognized.

Older male COVID-19 patients are more likely to experience hair loss.

Female authorship in dermatology publications increased during the COVID-19 pandemic, but women are still underrepresented in senior roles.

Different races and genders have unique skin and hair issues, requiring specialized care and more research for effective treatment.

Eating disorders in gender dysphoria patients may be a coping mechanism for body image issues.

Women are more likely than men to hide their age due to societal pressures.

Hormone therapy can improve mental health and quality of life for people with gender dysphoria, but long-term effects need more research.

Pediatric dermatologists need to understand the unique skin health needs of LGBTQIA youth to provide better care.

The document concludes that hormone therapy is essential for treating gender dysphoria, with specific drugs and monitoring protocols recommended for safety and effectiveness.

Facial hair is crucial for transgender men's gender identity and transition.

The document concludes that individualized Facial Feminization Surgery plans and comprehensive care are crucial for successful outcomes.

The document concludes that treatments for hair loss in transgender and gender-diverse individuals include topical solutions, oral medications, laser therapy, and hair restoration procedures, with progress assessed after 6-12 months.

PCOS negatively affects self-esteem and social functioning in adolescent girls.

Estrogen alone can lower testosterone in some transfeminine people.

Estrogen alone may effectively suppress testosterone in some transfeminine individuals.

Hormonal therapy in adults with gender dysphoria often leads to skin issues like acne, requiring a team of skin and hormone doctors.

Plastic surgery marketing in the U.S. often overlooks men, but targeted campaigns can significantly increase male clientele for cosmetic procedures.

Testosterone treatment effectively causes male physical development in transgender male adolescents but may lead to side effects like acne, higher BMI and blood pressure, lower good cholesterol, and decreased bone density.

Hair pain is more common in women with hair loss, but it's not linked to the cause or severity of hair loss.

BMI is not a significant predictor of complications after gender-affirming penile inversion vaginoplasty.

Men prefer less invasive cosmetic procedures and need different treatment approaches than women.

Skin diseases in Turkish children vary by age and gender, with infections, eczema, acne, and allergies most common.

Age, gender, and hair loss affect scalp characteristics differently in young Caucasian adults.

Late diagnosis of congenital adrenal hyperplasia can greatly affect physical development, gender identity, and sexual health.

Testosterone pellets might work for transgender men's hormone therapy, but more research is needed.